According to Gram Research analysis, a study of specially designed mice found that prelamin A—a protein that accumulates during aging—does not cause atherosclerosis (clogged arteries) or damage blood vessel muscle cells, even in mice with high cholesterol. This challenges the theory that prelamin A accumulation drives age-related heart disease, suggesting instead that other factors may be more important in vascular aging.
Scientists studied a protein called prelamin A that builds up in the body as we age. They wanted to know if this protein damages blood vessels and causes heart disease, like it does in a rare childhood aging disease called Hutchinson-Gilford progeria syndrome. Using specially designed mice, researchers found something surprising: prelamin A by itself doesn’t seem to damage blood vessels or cause the kind of heart disease damage they expected. This finding challenges what scientists previously believed and suggests that other factors might be more important in age-related heart disease than this particular protein.
Key Statistics
A 2026 research study in mice found that exclusive prelamin A expression did not increase atherosclerotic plaque size or necrotic core area compared to mice expressing normal lamin A, even when both groups had high cholesterol from a high-fat diet.
Mice expressing only prelamin A showed no loss of aortic smooth muscle cells at either 28 weeks or 52 weeks of age, indicating that prelamin A does not promote vascular smooth muscle cell death during aging.
Unlike progerin (the mutated form of prelamin A in Hutchinson-Gilford progeria syndrome), normal prelamin A did not trigger abnormal cell proliferation or apoptosis in blood vessel tissue, suggesting the specific mutation—not just unprocessed prelamin A—causes vascular damage in progeria.
The Quick Take
- What they studied: Whether a protein that accumulates during aging (prelamin A) causes heart disease and damages blood vessel walls, similar to what happens in a rare rapid-aging disease.
- Who participated: Laboratory mice genetically engineered to produce only prelamin A instead of normal, processed lamin A protein. Some mice were also bred to develop high cholesterol and atherosclerosis (clogged arteries).
- Key finding: Mice that produced only prelamin A did not develop more atherosclerosis (clogged arteries) or lose muscle cells in their blood vessel walls compared to normal mice, even when they had high cholesterol.
- What it means for you: This research suggests that prelamin A alone may not be the main driver of age-related heart disease in humans, though more research is needed. It doesn’t change current heart disease prevention strategies, but it helps scientists understand which proteins actually cause aging-related vascular damage.
The Research Details
Researchers created a special mouse model (LmnaL648R/L648R) that produces only prelamin A—an unprocessed form of a structural protein found in cell nuclei. Normally, this protein gets processed into a mature form, but these mice couldn’t complete that process. The scientists then crossed these mice with another mouse strain that develops high cholesterol and clogged arteries when fed a high-fat diet, creating mice that had both the prelamin A condition and atherosclerosis risk factors.
The researchers examined the mice’s arteries at two different ages (28 weeks and 52 weeks) to see if prelamin A caused atherosclerotic plaques (fatty deposits in arteries), damaged the muscle layer of blood vessels, or caused other vascular problems. They measured plaque size, the amount of dead tissue in plaques, muscle cell loss, and whether cells were dividing or dying abnormally.
This approach allowed scientists to isolate the effects of prelamin A specifically, since the mice either had it or didn’t, while controlling for other genetic factors.
Understanding which proteins actually cause age-related heart disease is crucial for developing treatments. Scientists previously thought that prelamin A accumulation might be a major problem during aging, similar to how a mutated version of this protein (progerin) causes severe vascular damage in Hutchinson-Gilford progeria syndrome. This study tests that assumption directly by examining whether the normal form of prelamin A has the same damaging effects.
This is a controlled laboratory study using genetically modified mice, which allows researchers to isolate specific variables. The study examined mice at multiple time points and measured multiple outcomes (plaque size, cell death, muscle loss). However, mouse studies don’t always translate directly to humans, and the study doesn’t specify exact sample sizes for each group. The research was published in a peer-reviewed journal focused on vascular biology, suggesting it underwent expert review.
What the Results Show
The main finding was that mice expressing only prelamin A did not develop larger atherosclerotic plaques or more severe plaque damage compared to normal mice, even when both groups had high cholesterol. At 28 weeks of age, there was no difference in plaque size or the amount of dead tissue within plaques between the two groups. The researchers also found no loss of smooth muscle cells in the aorta (the body’s largest artery) in the prelamin A mice.
When the researchers examined older mice at 52 weeks of age, the results remained the same—prelamin A expression still did not cause muscle cell loss in blood vessel walls. Additionally, they found no abnormal cell division or cell death in the blood vessel tissue of prelamin A mice, suggesting the protein wasn’t triggering cellular damage mechanisms.
These results were striking because they contradicted the researchers’ initial hypothesis. Many scientists had assumed that prelamin A accumulation during normal aging might contribute to heart disease, similar to how progerin (a mutated form of prelamin A) causes severe vascular damage in Hutchinson-Gilford progeria syndrome. This study suggests that the normal form of prelamin A, even when it accumulates, doesn’t have the same damaging effects.
The study confirmed that the LmnaL648R/L648R mice did show other aging-related problems consistent with previous research, including bone defects, reduced body fat, and lower body weight. This validated that the mice were indeed expressing the prelamin A variant as intended. The fact that these mice showed some aging-related symptoms but not vascular damage suggests that prelamin A affects different tissues in different ways.
Previous research had suggested two competing ideas: (1) that progerin, the mutated form of prelamin A in Hutchinson-Gilford progeria syndrome, causes vascular damage by triggering smooth muscle cell loss, and (2) that accumulation of normal prelamin A during regular aging might also contribute to heart disease. This study supports the first idea while challenging the second. The findings suggest that the specific mutation in progerin (not just the presence of unprocessed prelamin A) is what causes the severe vascular damage seen in progeria syndrome.
The study used laboratory mice, which don’t always behave exactly like human bodies. Mice have different lifespans, metabolism, and genetic backgrounds than humans. The study doesn’t specify the exact number of mice used in each group, making it difficult to assess statistical power. Additionally, while the mice were fed a high-fat diet to trigger atherosclerosis, this doesn’t perfectly replicate all the factors that contribute to heart disease in humans. The study also only examined one specific genetic variant of prelamin A, so results might not apply to other forms of the protein or other aging-related conditions.
The Bottom Line
This research does not suggest any changes to current heart disease prevention strategies. Continue following established recommendations: maintain a healthy diet low in saturated fat, exercise regularly, manage cholesterol and blood pressure, and avoid smoking. This study is primarily important for scientists studying aging mechanisms, not for individual health decisions. Confidence level: This is basic research that informs scientific understanding but doesn’t directly guide personal health choices.
This research is most relevant to scientists studying aging and vascular disease, as well as researchers working on treatments for Hutchinson-Gilford progeria syndrome. It may eventually help doctors develop better treatments for age-related heart disease by identifying which proteins actually cause damage. People with progeria syndrome or a family history of early heart disease might find this research interesting, but it doesn’t change their current medical care.
This is fundamental research that contributes to long-term scientific understanding. It doesn’t offer immediate health benefits or treatments. Scientists will need to conduct additional studies to understand what actually causes age-related vascular damage if prelamin A isn’t the main culprit.
Frequently Asked Questions
Does the protein that builds up as we age cause heart disease?
A 2026 mouse study found that prelamin A, a protein that accumulates with age, did not cause atherosclerosis or damage blood vessel walls, even in mice with high cholesterol. This suggests other factors may be more important in age-related heart disease.
What’s the difference between prelamin A and progerin in terms of heart damage?
Progerin, the mutated form in Hutchinson-Gilford progeria syndrome, causes severe vascular damage and smooth muscle cell loss. Normal prelamin A, even when unprocessed, does not cause these effects in mice, indicating the specific mutation—not just the unprocessed form—drives the damage.
Can I reduce prelamin A buildup to prevent heart disease?
This research doesn’t suggest prelamin A buildup is a major cause of age-related heart disease, so targeting it isn’t a proven prevention strategy. Focus instead on established approaches: manage cholesterol and blood pressure, exercise regularly, eat a healthy diet, and avoid smoking.
Does this research change how doctors treat aging-related heart disease?
This is basic research that helps scientists understand aging mechanisms. It doesn’t immediately change treatment approaches, but it redirects research toward identifying which proteins actually cause vascular aging, potentially leading to better future treatments.
Should people with progeria syndrome worry less about heart disease based on this study?
No. This study shows that normal prelamin A doesn’t cause damage, but progeria patients have a mutated form (progerin) that does cause severe vascular problems. People with progeria still need careful cardiac monitoring and treatment as recommended by their doctors.
Want to Apply This Research?
- While this study doesn’t directly suggest new tracking metrics, users interested in vascular health could track established cardiovascular risk factors: blood pressure readings, cholesterol levels (if available through connected devices), exercise minutes per week, and dietary saturated fat intake. This helps monitor factors that research shows actually do affect heart disease risk.
- Focus on proven heart disease prevention strategies: aim for 150 minutes of moderate exercise weekly, reduce saturated fat intake to less than 7% of daily calories, maintain a healthy weight, and manage stress. Users can set weekly goals for these evidence-based behaviors rather than worrying about aging proteins they can’t directly control.
- Track cardiovascular health markers over months and years: blood pressure trends, cholesterol levels, weight, and exercise consistency. This long-term monitoring helps identify whether lifestyle changes are reducing actual heart disease risk factors, which is more meaningful than tracking theoretical protein accumulation.
This research is a laboratory study in mice and does not directly apply to human health decisions. The findings do not suggest changes to current heart disease prevention strategies. Anyone with concerns about heart disease risk, family history of early heart disease, or diagnosed cardiovascular conditions should consult with their healthcare provider. This article is for educational purposes and should not be considered medical advice. If you have Hutchinson-Gilford progeria syndrome or a family history of this condition, discuss this research with your medical team, as it may inform future treatment approaches but does not change current care recommendations.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.